David Ledbetter, Ph.D., FACMG

Dr.Ledbetter is a human geneticist with ABMGG board-certification in clinical cytogenetics. Since his discovery of the genetic causes of Prader-Willi syndrome and Miller-Dieker syndrome, his research has focused on developing and applying technologies to better understand neurodevelopmental conditions such as autism spectrum disorders. He has held leadership positions at NIH, the University of Chicago, and Emory University and is currently the executive vice president and chief scientific officer of Geisinger Health System.